Severe Aplastic Anemia (SAA) Clinical Trial
Official title:
Two Arm Bridging Study to Evaluate the Efficacy of Romiplostim in the Treatment of Adult Severe Aplastic Anemia Participants Who Are Either Previously Untreated With IST or Refractory to IST
Romiplostim has been used in clinical trials for the treatment of severe and very severe aplastic anemia (SAA/vSAA) in Asian participants who are either previously untreated with immunosuppressive therapy (IST) or refractory to IST. This study will evaluate the efficacy of romiplostim in the treatment of participants with SAA/vSAA. The primary objectives of this study are to: Arm 1: Evaluate the efficacy of romiplostim and IST in adult SAA/vSAA participants who are previously untreated with IST (1L) Arm 2: Evaluate the efficacy of romiplostim treatment in adult SAA/vSAA participants who are refractory to IST (2L+)
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04328727 -
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
|
Phase 2 | |
| Completed |
NCT00604201 -
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome
|
Phase 2 | |
| Completed |
NCT01891994 -
Extended Dosing With Eltrombopag for Severe Aplastic Anemia
|
Phase 2 | |
| Completed |
NCT00001626 -
Comparing Therapies for the Treatment of Severe Aplastic Anemia
|
Phase 2 | |
| Recruiting |
NCT04409080 -
REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03520647 -
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
|
Phase 2 | |
| Completed |
NCT01900119 -
A Description of Bacteria in the Mouths of Patients With Severe Aplastic Anemia
|